Etsuko Tate
Overview
Explore the profile of Etsuko Tate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hama Y, Tate E
J Radiosurg SBRT
. 2024 Aug;
9(2):129-133.
PMID: 39087063
Purpose: Despite the efficacy of endorectal balloon (ERB) in reducing rectal radiation dose, the effectiveness of upper rectal fixation remains to be evaluated. The purpose of this study was to...
2.
Kurosaki H, Okazaki K, Takemori M, Tate E, Nakamura T
Cureus
. 2024 May;
16(4):e57417.
PMID: 38694683
Boron neutron capture therapy (BNCT) has predominantly been performed for brain tumors or head and neck cancers. Although BNCT is known to be applicable to breast cancer, it has only...
3.
Hama Y, Tsukamoto T, Tate E
Strahlenther Onkol
. 2023 Jun;
200(2):123-127.
PMID: 37264179
Purpose: The purpose of this study was to investigate the feasibility and effectiveness of high-dose planned adaptive intensity-modulated radiation therapy (IMRT) with helical tomotherapy (HT) for cutaneous angiosarcoma (cAS) of...
4.
Hama Y, Tate E
Rep Pract Oncol Radiother
. 2022 Dec;
27(5):842-847.
PMID: 36523793
Background: Endorectal balloon (ERB) has been shown to reduce rectal radiation dose and late gastrointestinal toxicities in patients with prostate cancer. However, the usefulness of ERBs for patients with prostate...
5.
Hama Y, Tate E
J Cancer Res Ther
. 2022 Dec;
18(Supplement):S489-S492.
PMID: 36511012
A 69-year-old man with a history of pancreatic cancer was referred to our hospital for a newly developed solitary liver metastasis. Since the liver metastasis was in contact with the...
6.
Kurosaki H, Hirayama K, Takahashi M, Uematsu M, Tate E
Cureus
. 2022 Dec;
14(10):e30949.
PMID: 36465793
Aim In this study, we compared three generations of tomotherapy (Hi-ART, Tomo-HD, and Radixact). This is to study the difference among tomotherapy systems in terms of dose distribution to planning...
7.
Hama Y, Tate E
J Radiosurg SBRT
. 2022 Oct;
8(2):105-108.
PMID: 36275133
Purpose: There are no detailed data on volume changes of SpaceOAR hydrogel spacer. The purpose of this study was to quantitatively evaluate the volume changes of SpaceOAR during radiation therapy...
8.
MRI findings of iatrogenic extravasation of gadolinium-based contrast agents in patients with cancer
Hama Y, Tate E
Acta Radiol
. 2022 Oct;
64(4):1439-1442.
PMID: 36221814
Background: Magnetic resonance imaging (MRI) findings after subcutaneous extravasation of gadolinium-based contrast agent (GBCA) have not been investigated in detail. Purpose: To present the MRI findings of iatrogenic extravasation and...
9.
Hama Y, Tate E
Br J Radiol
. 2022 Mar;
95(1135):20211131.
PMID: 35333542
Objectives: The purpose of this study was to investigate the changes of tumor-to-liver signal ratio in a 0.35T MRI-guided radiotherapy system and to evaluate the usefulness and pitfalls of superparamagnetic...
10.
Hama Y, Tate E
Cancer Invest
. 2022 Mar;
40(5):437-441.
PMID: 35236196
The purpose of this study was to investigate the efficacy and feasibility of high-dose (72.6 Gy) planned adaptive intensity-modulated radiation therapy (IMRT) with simultaneous integrated boost (SIB) for 9 consecutive...